Quest PharmaTech Inc. (TSXV:QPT)

Quest PharmaTech Income Statement

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Selling, General & Admin	0.47	0.49	0.82	0.54	0.64
Research & Development	0.24	0.33	0.5	0.3	0.15
Operating Expenses	0.71	0.82	1.32	0.83	0.79
Operating Income	-0.71	-0.82	-1.32	-0.83	-0.79
Interest Expense	-0.02	-0.02	-0.02	-0.02	-0.01
Earnings From Equity Investments	2.71	-0.8	-0.52	-3.1	-57.75
Currency Exchange Gain (Loss)	-0	0	-0	-0	-0
Other Non Operating Income (Expenses)	0.3	0.3	0.17	0.45	0.24
EBT Excluding Unusual Items	2.28	-1.34	-1.68	-3.5	-58.32
Gain (Loss) on Sale of Investments	2.72	-0.46	-1.34	-61.39	-26.72
Pretax Income	5	-1.8	-3.02	-64.89	-85.04
Earnings From Continuing Operations	5	-1.8	-3.02	-64.89	-85.04
Net Income to Company	5	-1.8	-3.02	-64.89	-85.04
Net Income	5	-1.8	-3.02	-64.89	-85.04
Net Income to Common	5	-1.8	-3.02	-64.89	-85.04
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	169	169	169	168	168
Shares Outstanding (Diluted)	169	169	169	168	168
Shares Change	-	-	0.44%	0.09%	-1.57%
EPS (Basic)	0.03	-0.01	-0.02	-0.39	-0.51
EPS (Diluted)	0.03	-0.01	-0.02	-0.39	-0.51
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Free Cash Flow	-0.19	-0.51	-0.34	-0.55	-0.17
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
EBITDA	-	-0.81	-1.31	-0.82	-0.79
D&A For EBITDA	-	0	0	0.01	0
EBIT	-0.71	-0.82	-1.32	-0.83	-0.79

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error